Therapeutics

Drug Discovery Pipeline

HTG Therapeutics is creating a pipeline focused on RNA-Modifying Proteins and other targets to be directed to disease areas such as Oncology, AutoImmune, Neurodegenerative, and Rare Disease.

Page last updated August 05, 2021